1. Medtech Insight
  2. >>Geography
  3. >>International

Q&A: IMDRF Releases Final Legacy Device Cybersecurity Guidance

 
• By Hannah Daniel

The International Medical Device Regulation Forum published its final guidance on principles and practices for legacy medical devices, and the document seems to be less about legacy devices and more about the total lifecycle of a device, compliance expert Eric Henry told Medtech insight.

Shutterstock

The International Medical Device Regulation Forum has published its final guidance on legacy device cybersecurity recommendations, but its scope extends beyond just legacy devices.

The last IMDRF draft for legacy device cybersecurity was published in May 2022. Legacy devices pose unique cybersecurity risks,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

‘From Diagnostics To Prognostics’: Google Cloud Healthcare Director Sees AI As Healthcare’s Future

 
• By Elizabeth Orr

Google Cloud healthcare lead Shweta Maniar talked with Medtech Insight about improving health monitoring, boosting regulatory collaboration, and deepening integration of technology in medical practices.

As Medtech Tariffs Loom, AdvaMed Responds With Its Own Plan Emphasizing ‘Reciprocal’ Free Trade

 
• By Brian Bossetta

The US Department of Commerce’s investigation into the national security impact of importing various medical equipment could lead to tariffs on many products. Device industry responds by emphasizing the robustness of domestic production, but also the rigidity of supply and reimbursement agreements.

Persistence Pays Off: New International Clinical Evaluation Standard Is Finally On Horizon

 
• By Amanda Maxwell

Clinical evaluation and standards expert Danielle Giroud celebrates progress on the document and looks at what it means internationally and for the EU.

Global Medtech Guidance Tracker: September 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

More from Geography

interview

What Exact-ly Is In Store For Liquid Biopsy?

 
• By Barnaby Pickering

Ahead of Exact Science’s $21bn dollar acquisition by Abbott, Medtech Insight spoke to the company’s chief medical officer, Tomasz Beer, to learn more about the company’s multi-cancer early detection offering, its wider portfolio of products and to hear more about the direction of the field.

LDTs Aimed At Catching Cancers Early Hold Promise In Reducing Late-Stage Diagnoses, Study Shows

 
• By Brian Bossetta

A recent study demonstrates that certain types of blood-based tests that screen for multiple cancers at once have the potential to flip the script on cancer diagnoses, including some of the deadliest types.

How The EU’s Digital Omnibus Package Could Provide Breathing Space For Medtech

 
• By Amanda Maxwell

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.